Literature DB >> 26124279

129-Derived Mouse Strains Express an Unstable but Catalytically Active DNA Polymerase Iota Variant.

Said Aoufouchi1, Annie De Smet2, Frédéric Delbos2, Camille Gelot3, Ida Chiara Guerrera4, Jean-Claude Weill2, Claude-Agnès Reynaud2.   

Abstract

Mice derived from the 129 strain have a nonsense codon mutation in exon 2 of the polymerase iota (Polι) gene and are therefore considered Polι deficient. When we amplified Polι mRNA from 129/SvJ or 129/Ola testes, only a small fraction of the full-length cDNA contained the nonsense mutation; the major fraction corresponded to a variant Polι isoform lacking exon 2. Polι mRNA lacking exon 2 contains an open reading frame, and the corresponding protein was detected using a polyclonal antibody raised against the C terminus of the murine Polι protein. The identity of the corresponding protein was further confirmed by mass spectrometry. Although the variant protein was expressed at only 5 to 10% of the level of wild-type Polι, it retained de novo DNA synthesis activity, the capacity to form replication foci following UV irradiation, and the ability to rescue UV light sensitivity in Polι(-/-) embryonic fibroblasts derived from a new, fully deficient Polι knockout (KO) mouse line. Furthermore, in vivo treatment of 129-derived male mice with Velcade, a drug that inhibits proteasome function, stabilized and restored a substantial amount of the variant Polι in these animals, indicating that its turnover is controlled by the proteasome. An analysis of two xeroderma pigmentosum-variant (XPV) cases corresponding to missense mutants of Polη, a related translesion synthesis (TLS) polymerase in the same family, similarly showed a destabilization of the catalytically active mutant protein by the proteasome. Collectively, these data challenge the prevailing hypothesis that 129-derived strains of mice are completely deficient in Polι activity. The data also document, both for 129-derived mouse strains and for some XPV patients, new cases of genetic defects corresponding to the destabilization of an otherwise functional protein, the phenotype of which is reversible by proteasome inhibition.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26124279      PMCID: PMC4525304          DOI: 10.1128/MCB.00371-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis.

Authors:  Jin Yang; Zhiwen Chen; Yang Liu; Robert J Hickey; Linda H Malkas
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

Review 2.  The association of nonsense codons with exon skipping.

Authors:  C R Valentine
Journal:  Mutat Res       Date:  1998-09       Impact factor: 2.433

3.  Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.

Authors:  Hiroko Yaguchi; Naganari Ohkura; Maho Takahashi; Yuko Nagamura; Issay Kitabayashi; Toshihiko Tsukada
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

4.  Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing.

Authors:  Deepak T Nair; Robert E Johnson; Satya Prakash; Louise Prakash; Aneel K Aggarwal
Journal:  Nature       Date:  2004-07-15       Impact factor: 49.962

5.  Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta.

Authors:  R E Johnson; S Prakash; L Prakash
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

6.  Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.

Authors:  Alexis Gautreau; Jan Manent; Bruno Fievet; Daniel Louvard; Marco Giovannini; Monique Arpin
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

7.  Pol iota is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia.

Authors:  Min Wang; Theodora R Devereux; Haris G Vikis; Scott D McCulloch; Wanda Holliday; Colleen Anna; Yian Wang; Katarzyna Bebenek; Thomas A Kunkel; Kunliang Guan; Ming You
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

8.  Identification of a higher molecular weight DNA polymerase alpha catalytic polypeptide in monkey cells by monoclonal antibody.

Authors:  E Karawya; J Swack; W Albert; J Fedorko; J D Minna; S H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 9.  Radiation and chemical activation of ras oncogenes in different mouse strains.

Authors:  E W Newcomb; L E Diamond; S R Sloan; M Corominas; I Guerrerro; A Pellicer
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

10.  129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation.

Authors:  John P McDonald; Ekaterina G Frank; Brian S Plosky; Igor B Rogozin; Chikahide Masutani; Fumio Hanaoka; Roger Woodgate; Patricia J Gearhart
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

View more
  3 in total

1.  Mouse DNA polymerase ι lacking the forty-two amino acids encoded by exon-2 is catalytically inactive in vitro.

Authors:  Ekaterina G Frank; John P McDonald; Wei Yang; Roger Woodgate
Journal:  DNA Repair (Amst)       Date:  2016-12-21

2.  DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress.

Authors:  Rui Wang; Walter F Lenoir; Chao Wang; Dan Su; Megan McLaughlin; Qianghua Hu; Xi Shen; Yanyan Tian; Naeh Klages-Mundt; Erica Lynn; Richard D Wood; Junjie Chen; Traver Hart; Lei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 12.779

3.  DNA polymerase ι functions in the generation of tandem mutations during somatic hypermutation of antibody genes.

Authors:  Robert W Maul; Thomas MacCarthy; Ekaterina G Frank; Katherine A Donigan; Mary P McLenigan; William Yang; Huseyin Saribasak; Donald E Huston; Sabine S Lange; Roger Woodgate; Patricia J Gearhart
Journal:  J Exp Med       Date:  2016-07-25       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.